Matt Utterback, MA

Mathew Utterback is a co-founder and General Partner of Impact Ventures Partners Fund, which is leading Viska Bio’s next round of funding. He began his career at the MIT Entrepreneurship Center and joined NewcoGen Group, the predecessor fund to Flagship Pioneering, in 2001. Since then, he has built and invested in startups globally. He currently supports the Viska Bio team in their work to develop effective new therapies for glioblastoma.